Harish P. Janardhan

University of Massachusetts Chan Medical School

MedicineBiochemistry, Genetics and Molecular BiologyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K–MAPK1 inhibition”.

KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K–MAPK1 inhibition

The Journal of Experimental Medicine(2020)10.1084/jem.20192205

N/A

0DataRank · unranked

19 citations

Xiuling Meng, Karen Dresser, Lloyd Hutchinson, Chinmay M. Trivedi, Harish P. Janardhan

Pathological MAPK activation–mediated lymphatic basement membrane disruption causes lymphangiectasia that is treatable with ravoxertinib

JCI Insight(2022)10.1172/jci.insight.153033

N/A

0DataRank · unranked

11 citations

Karen Dresser, Lloyd Hutchinson, Chinmay M. Trivedi, Harish P. Janardhan

Lymphatic System in Organ Development, Function, and Regeneration

Circulation Research(2023)10.1161/circresaha.123.322867

N/A

0DataRank · unranked

15 citations

Roy Jung, Chinmay M. Trivedi, Harish P. Janardhan

Lymphatic System Development and Function

Current Cardiology Reports(2024)10.1007/s11886-024-02120-8

N/A

0DataRank · unranked

4 citations

Brianna T. Wachter, Chinmay M. Trivedi, Harish P. Janardhan